| Literature DB >> 27670941 |
Bryan J Feger1, J Will Thompson2, Laura G Dubois2, Reddy P Kommaddi3, Matthew W Foster2,3, Rajashree Mishra1, Sudha K Shenoy3, Yoichiro Shibata4, Yared H Kidane5,6, M Arthur Moseley2, Lisa S Carnell7, Dawn E Bowles1.
Abstract
On Earth, biological systems have evolved in response to environmental stressors, interactions dictated by physical forces that include gravity. The absence of gravity is an extreme stressor and the impact of its absence on biological systems is ill-defined. Astronauts who have spent extended time under conditions of minimal gravity (microgravity) experience an array of biological alterations, including perturbations in cardiovascular function. We hypothesized that physiological perturbations in cardiac function in microgravity may be a consequence of alterations in molecular and organellar dynamics within the cellular milieu of cardiomyocytes. We used a combination of mass spectrometry-based approaches to compare the relative abundance and turnover rates of 848 and 196 proteins, respectively, in rat neonatal cardiomyocytes exposed to simulated microgravity or normal gravity. Gene functional enrichment analysis of these data suggested that the protein content and function of the mitochondria, ribosomes, and endoplasmic reticulum were differentially modulated in microgravity. We confirmed experimentally that in microgravity protein synthesis was decreased while apoptosis, cell viability, and protein degradation were largely unaffected. These data support our conclusion that in microgravity cardiomyocytes attempt to maintain mitochondrial homeostasis at the expense of protein synthesis. The overall response to this stress may culminate in cardiac muscle atrophy.Entities:
Year: 2016 PMID: 27670941 PMCID: PMC5037457 DOI: 10.1038/srep34091
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Overview of study work flow.
(A) Schematic overview of SILAC experiments. NRCMs were placed in SILAC and split into groups designated for 12, 48, and 120 h following which cell pellets were analyzed. (B) Mass Spectrometry work flow. Cell pellets were lysed, proteins were digested and analyzed by area under the curve (AUC) following separation through LC/MS/MS.
Figure 2Protein abundance is altered in cardiomyocytes during simulated microgravity.
(A) Principal components analysis (PCA) was performed using protein data from Supplemental Table S3, z-score normalized. The smallest variability among any sample group is among 0 h and 12 h samples, followed by 48 h and 120 h. The QC pool samples are nearly indistinguishable in the center of the PCA, showing technical variability is far less than biological variability. (B) Fraction of proteins that changed as a function of time or between groups.
Figure 3Protein turnover is diminished in microgravity.
(A) A statistical box plot for the precursor amino acid ‘pool’ RIA calculated using the I/I and I/I forms of the double-lysine containing peptide EATNPPIIQEEKPK from Protein Disulfide Isomerase A3, including 48 h and 120 h time points. These data show no difference in the amino acid pool available for protein synthesis inside the cell between 1xg and μg condition (p = 0.80, Students T-test). (B) Statistical boxplots for RIA calculated for 359 highly-curated peptide pairs as a function of time under either 1xg or μg environment. Peptide RIA, a measure of protein turnover, was not different at 12 h (p = 0.32, Students T-test) but showed statistically significant slowing under μg at 48 and 120 h (p < 1e-6, Students T-test). Boxes represent quartiles.
Gene Set Enrichment Analysis for Protein Abundance Data.
| UP-REGULATED | FDR |
|---|---|
| METABOLIC | |
| CARBOXYLIC_ACID_METABOLIC_PROCESS | 3.36E-002 |
| FATTY_ACID_METABOLIC_PROCESS | 3.11E-002 |
| KEGG_FATTY_ACID_METABOLISM | 1.40E-002 |
| MONOCARBOXYLIC_ACID_METABOLIC_PROCESS | 3.07E-002 |
| ORGANIC_ACID_METABOLIC_PROCESS | 3.48E-002 |
| REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM | 3.80E-002 |
| REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES | 4.85E-002 |
| REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS | 3.45E-002 |
| REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE | 6.93E-004 |
| MITOCHONDRION | |
| MITOCHONDRIAL_LUMEN | 3.74E-002 |
| MITOCHONDRIAL_MATRIX | 3.91E-002 |
| MITOCHONDRIAL_MEMBRANE | 4.68E-002 |
| MITOCHONDRIAL_PART | 3.57E-003 |
| MITOCHONDRION | 0.00E + 000 |
| ELECTRON TRANSPORT | |
| REACTOME_RESPIRATORY_ELECTRON_TRANSPORT | 4.69E-002 |
| REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_ | 3.19E-002 |
| REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT | 2.61E-004 |
| CYTOPLASMIC_PART | 3.71E-002 |
| KEGG_CITRATE_CYCLE_TCA_CYCLE | 3.45E-002 |
| REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE | 3.62E-004 |
| KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION | 9.91E-003 |
| OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NADH_OR_NADPH | 3.61E-002 |
| DISEASES | |
| KEGG_ALZHEIMERS_DISEASE | 3.29E-002 |
| KEGG_HUNTINGTONS_DISEASE | 1.74E-002 |
| KEGG_PARKINSONS_DISEASE | 3.33E-002 |
| DOWN-REGULATED | |
| KEGG_RIBOSOME | 3.98E-002 |
| REACTOME_INFLUENZA_LIFE_CYCLE | 4.50E-002 |
| REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION | 4.48E-002 |
| REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE | 2.50E-002 |
Gene Set Enrichment Analysis for Protein Turnover Data.
| UP-REGULATED | FDR |
|---|---|
| MITOCHONDRION | |
| MITOCHONDRIAL_ENVELOPE | 4.78E-004 |
| MITOCHONDRIAL_INNER_MEMBRANE | 3.65E-003 |
| MITOCHONDRIAL_MEMBRANE | 1.12E-003 |
| MITOCHONDRIAL_MEMBRANE_PART | 5.26E-002 |
| MITOCHONDRIAL_PART | 8.56E-005 |
| MITOCHONDRION | 0.00E + 000 |
| ENVELOPE | 3.63E-003 |
| ORGANELLE_ENVELOPE | 4.13E-003 |
| ORGANELLE_INNER_MEMBRANE | 3.49E-003 |
| REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS | 4.45E-003 |
| ELECTRON TRANSPORT | |
| ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY | 2.79E-002 |
| ELECTRON_TRANSPORT_GO_0006118 | 9.26E-002 |
| ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY | 1.54E-002 |
| REACTOME_RESPIRATORY_ELECTRON_TRANSPORT | 3.28E-002 |
| REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_ | 1.87E-003 |
| REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT | 6.48E-005 |
| REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES | 8.61E-002 |
| KEGG_CITRATE_CYCLE_TCA_CYCLE | 5.89E-003 |
| REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE | 6.47E-002 |
| REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING | 8.66E-002 |
| KEGG_OXIDATIVE_PHOSPHORYLATION | 3.95E-003 |
| DISEASES | |
| KEGG_ALZHEIMERS_DISEASE | 8.00E-003 |
| KEGG_HUNTINGTONS_DISEASE | 9.80E-004 |
| KEGG_PARKINSONS_DISEASE | 5.81E-003 |
| MUSCLE DEVELOPMENT AND CONTRACTION | |
| KEGG_CARDIAC_MUSCLE_CONTRACTION | 4.50E-003 |
| HEART_DEVELOPMENT | 1.04E-002 |
| MUSCLE_DEVELOPMENT | 1.05E-002 |
| REGULATION_OF_HEART_CONTRACTION | 5.16E-002 |
| DOWN-REGULATED | |
| ESTABLISHMENT_OF_PROTEIN_LOCALIZATION | 6.68E-002 |
| MACROMOLECULE_LOCALIZATION | 7.70E-002 |
| PROTEIN_LOCALIZATION | 8.78E-002 |
Figure 4Gene Ontology.
(A) Comparison of enrichment of Gene Ontology cellular components for protein abundance and turnover data sets. (B) Leading genes that contributed to the difference and similarity in the perturbation of the cellular components shown in panel A. A 0.05 FDR cutoff value was used for this analysis.
Individual protein abundance alterations in microgravity.
| Primary Protein Name | Protein Description | %CV | FC @ 120 h ( | Function |
|---|---|---|---|---|
| 392351353 | Myosin-13 | 9.9 | 3.5 | Molecular motor |
| 11693154 | Platelet-activating factor acetylhydrolase IB subunit beta | 11.5 | 2.7 | Activity of RhoGTPases, actin polymerization |
| 198442897 | AFG3-like protein 2 | 10.3 | 2.5 | Mitochondrial protein homeostasis |
| 9507135 | Spectrin beta chain, brain 2 | 5.2 | 2.1 | Actin binding |
| 293359790 | Protein FAM179A-like isoform 1 | 3.6 | 1.9 | Unknown function |
| 62945328 | Protein NipSnap homolog 2 | 11.9 | 1.8 | Mitochondria, neg regulation of ATP citrate synthase activity |
| 25742739 | Long-chain-fatty-acid–CoA ligase 1 | 2.5 | 1.7 | Activates breakdown of complex FA |
| 48675862 | Acyl-coenzyme A thioesterase 2, mitochondrial | 2.0 | 1.7 | Catalyzes hydrolysis of acyl-CoA to free FA and co enzyme A |
| 392347468 | Poly (rC)-binding protein 1 | 6.2 | 1.6 | mrna import to mitochondria |
| 56605722 | Serine hydroxymethyltransferase, mitochondrial | 6.2 | 1.6 | Conversion l-serine to glycine, provides 1 carbon units to cell |
| 113205496 | Pyruvate dehydrogenase complex, component X | 2.1 | 1.6 | Mitochondrial, tether E3 dimers to E2 core |
| 392341350 | Glyceraldehyde-3-phosphate dehydrogenase-like | 1.3 | 1.5 | Breaks down glucose for energy and carbon |
| 13994225 | 3-hydroxyacyl-CoA dehydrogenase type-2 | 8.6 | 1.5 | Mitochondrial tRNA maturation |
| 11968102 | Ornithine aminotransferase, mitochondrial precursor | 5.2 | 1.5 | Processes excess nitrogen during protein breakdown |
| 392351018 | Sarcalumenin | 3.2 | 1.5 | Calcium buffering in SR |
| 410110929 | Stress-70 protein, mitochondrial | 3.1 | 1.5 | Mitochondrial protein homeostasis |
| 209954804 | Plastin-3 | 9.5 | −24.3 | EF-hand protein, bone? |
| 293346882 | Mitochondrial aspartate aminotransferase-like | 18.0 | −22.2 | metabolite exchange between mitochondria and cytosol, uptake of long chain free fatty acids |
| 8394079 | Proteasome subunit beta type-2 | 11.8 | −15.4 | ATP dependent proteolytic activity |
| 157818179 | Elongation factor 1-beta | 5.3 | −13.4 | Translation elongation, gdp to gtp exchange |
| 157787127 | 40 S ribosomal protein S28 | 8.2 | −12.6 | Ribosomal protein, translation |
| 392348740 | Laminin subunit beta-1 | 4.2 | −12.2 | ECM structural component |
| 77993298 | Translocon-associated protein subunit alpha precursor | 5.3 | −12.0 | ER protein, ER UPR |
| 12018252 | Transketolase | 14.2 | −8.9 | Pentose phosphate pathway |
| 56744249 | Reticulocalbin 3, EF-hand calcium binding domain precursor | 4.9 | −7.6 | ER Calcium binding |
| 40254781 | Rab GDP dissociation inhibitor beta | 15.7 | −6.8 | Regulates gdp/gtp exchange of most rab proteins, poly A RNA binding |
| 392342369 | 60 S ribosomal protein L30-like | 3.9 | −6.7 | Ribosomal protein, translation |
| 6981326 | Protein S100-A4 | 7.0 | −6.5 | Ca binding, polyA RNA binding |
| 61556832 | Adenine phosphoribosyltransferase | 13.5 | −6.3 | AMP biosynthesis salvage pathway |
| 6981574 | SPARC precursor | 15.7 | −6.2 | Regulates cell growth, thru ECM and binds calcium |
| 27665858 | 40 S ribosomal protein S9-like | 12.2 | −5.9 | Ribosomal structural protein |
| 392346755 | Ribosome-binding protein 1 | 14.7 | −5.6 | Mediates interaction between ribosome and ER |
| 392347136 | Collagen alpha-2(I) chain-like isoform 1 | 7.2 | −5.5 | Extracellular matrix |
| 13592133 | Actin, cytoplasmic 1 | 3.7 | −5.3 | motility |
| 203097140 | Myosin regulatory light chain RLC-A | 9.0 | −5.2 | Muscle contraction |
| 392348865 | Histone H2A. V-like | 4.5 | −4.7 | Chromosomal binding |
| 77404180 | Ras-related protein Rab-4A | 12.5 | −4.6 | ATPase activator activity |
| 157819753 | Reticulocalbin-1 precursor | 13.3 | −4.5 | ER calcium binding |
| 61556967 | Elongation factor 1-delta | 9.3 | −4.1 | Transfer of aminoacyl-tRNA to ribosome |
| 6981672 | Tropomyosin alpha-4 chain | 13.0 | −3.7 | Muscle contraction |
| 6978589 | Non-muscle caldesmon | 5.7 | −3.6 | Muscle contraction |
| 157822227 | 60 S ribosomal protein L12 | 7.8 | −3.4 | translation |
| 148747365 | Heat shock protein HSP 90-beta | 2.3 | −3.4 | Classic heat shock protein |
| 392356007 | Actin, cytoplasmic 1-like | 5.0 | −3.3 | Cell motility |
| 9506845 | Rab GTPase-binding effector protein 1 | 15.1 | −3.2 | Membrane trafficking, protein localization |
| 157786744 | Dihydropyrimidinase-related protein 2 | 4.5 | −3.0 | Cytoskeletal organization |
| 6981240 | Myosin light chain 3 | 4.3 | −2.5 | Muscle contraction |
| 124107592 | Unconventional myosin-Ic | 6.1 | −2.3 | Associated with transcriptionally active ribosomal genes |
| 12083607 | 40 S ribosomal protein S14-like | 2.5 | −2.2 | translation |
| 56090293 | Pyruvate dehydrogenase E1 component subunit beta, mitochondrial precursor | 4.1 | −2.1 | metabolism |
| 219275589 | Asparaginyl-tRNA synthetase, cytoplasmic isoform 2 | 3.5 | −2.1 | translation |
| 293350511 | M2 pyruvate kinase-like isoform 1 | 2.1 | −2.0 | metabolism |
| 155369650 | Myosin light polypeptide 6 | 6.2 | −1.8 | Muscle contraction |
| 11968086 | Ribosomal protein L4 | 5.1 | −1.7 | translation |
| 66730475 | Tropomyosin beta chain | 7.2 | −1.6 | Muscle contraction |
| 6981236 | Myosin-9 | 4.8 | −1.6 | Cytoskeletal organization |
| 6981666 | Troponin T, cardiac muscle | 3.5 | −1.5 | Cardiac structure |
Figure 5Surrogates of cell damage and protein degradation.
(A) LDH release was not significantly different among groups (n = 4). (B) Caspase-3 activity was not different among groups (n = 3). (C) A bar chart representing the immunoblot of protein ubiquitination; there was no significant difference among groups. (D) Representative immunoblot of ubiquitinated proteins using antibody clone P4D1 (n = 3). LDH, lactate dehydrogenase; RLU, relative light unit.
Figure 6Translation is diminished in microgravity.
(A) Immunoblot of biotin-tagged AHA, a methionine analog, and loading control FKBP12, together representing the decline in protein synthesis in μg at 120 h (n = 3, p = 0.003). AHA was added to the media for 2 hours at both 0 h and 120 h time points. (B) A bar chart representing the quantification of the densities of the AHA immunoblot. (C) Luciferase activity was markedly reduced in μg (n = 4, p = 0.02). AHA, azidohomoalanine; RLU, relative light unit.